INOVIO PHARMACEUTICALS, INC. Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
INOVIO PHARMACEUTICALS, INC. (INO) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 1.93% for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2018-05-09
- INOVIO PHARMACEUTICALS, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2018-03-31 was 1.93%, a 87.38% increase year-over-year.
- INOVIO PHARMACEUTICALS, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2017-03-31 was 1.03%, a 28.75% increase year-over-year.
- INOVIO PHARMACEUTICALS, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2016-03-31 was 0.80%, a 19.19% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2015-03-31 was 0.99%.
- INOVIO PHARMACEUTICALS, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2017 was 1.75%, a 59.09% increase from fiscal 2016.
- INOVIO PHARMACEUTICALS, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2016 was 1.10%, a 19.12% decline from fiscal 2015.
- INOVIO PHARMACEUTICALS, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2015 was 1.36%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 6 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 9 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | 1.93% 10-Q · filed 2018-05-09 | |||
| 2017-12-31 | 1.75% 10-K · filed 2018-03-14 | |||
| 2017-09-30 | 1.31% 10-Q · filed 2017-11-08 | |||
| 2017-06-30 | 1.24% 10-Q · filed 2017-08-08 | |||
| 2017-03-31 | 1.03% 10-Q · filed 2017-05-10 | |||
| 2016-12-31 | 1.10% 10-K · filed 2018-03-14 | |||
| 2016-09-30 | 0.73% 10-Q · filed 2016-11-09 | |||
| 2016-06-30 | 0.58% 10-Q · filed 2016-08-08 | |||
| 2016-03-31 | 0.80% 10-Q · filed 2016-05-09 | |||
| 2015-12-31 | 1.36% 10-K · filed 2017-03-15 | |||
| 2015-09-30 | 0.92% 10-Q · filed 2015-11-09 | |||
| 2015-06-30 | 1.01% 10-Q · filed 2015-08-10 | |||
| 2015-03-31 | 0.99% 10-Q · filed 2015-05-11 | |||
| 2014-09-30 | 1.43% 10-Q · filed 2014-11-10 | |||
| 2014-06-30 | 1.25% 10-Q · filed 2014-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |